临床试验

CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Proximal Popliteal Artery

NCT：NCT05734157 · COMPLETED

NCT编号NCT05734157

状态COMPLETED

开始日期2022-02-17

完成时间2025-08-27

SponsorAbbott Medical Devices (INDUSTRY)

First posted2023-02-17

Last updated2026-05-13

简要摘要

The CVT-SFA Trial investigates the inhibition of restenosis using the CVT Everolimus-coated PTA Catheter in the treatment of de-novo occluded/ stenotic or re-occluded/restenotic superficial femoral or popliteal arteries.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。